| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |